AU6957198A - Cytokine and cisplatin-based gene therapy of carcinomas - Google Patents
Cytokine and cisplatin-based gene therapy of carcinomasInfo
- Publication number
- AU6957198A AU6957198A AU69571/98A AU6957198A AU6957198A AU 6957198 A AU6957198 A AU 6957198A AU 69571/98 A AU69571/98 A AU 69571/98A AU 6957198 A AU6957198 A AU 6957198A AU 6957198 A AU6957198 A AU 6957198A
- Authority
- AU
- Australia
- Prior art keywords
- carcinomas
- cisplatin
- cytokine
- gene therapy
- based gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4278897P | 1997-04-07 | 1997-04-07 | |
US60042788 | 1997-04-07 | ||
PCT/US1998/006977 WO1998044934A1 (en) | 1997-04-07 | 1998-04-07 | Cytokine and cisplatin-based gene therapy of carcinomas |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6957198A true AU6957198A (en) | 1998-10-30 |
Family
ID=21923749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU69571/98A Abandoned AU6957198A (en) | 1997-04-07 | 1998-04-07 | Cytokine and cisplatin-based gene therapy of carcinomas |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6957198A (en) |
WO (1) | WO1998044934A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19944262A1 (en) * | 1999-09-15 | 2001-03-29 | Cardiogene Gentherapeutische S | Pharmaceutical composition in the form of a nucleic acid-lipid complex, its production and use in gene therapy |
-
1998
- 1998-04-07 WO PCT/US1998/006977 patent/WO1998044934A1/en active Application Filing
- 1998-04-07 AU AU69571/98A patent/AU6957198A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998044934A1 (en) | 1998-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4787697A (en) | Therapeutic gene | |
AU9676198A (en) | Drug delivery and gene therapy delivery system | |
AU5136093A (en) | Peptide antagonists of sh2 binding and therapeutic uses thereof | |
AU6316098A (en) | Miniaturized source of ionizing radiation and method of delivering same | |
AU1403199A (en) | Local delivery of therapeutic agents | |
AU6616498A (en) | Iontophoretic transdermal delivery and control of adverse side-effects | |
AU7954794A (en) | Modulation of drug radiation resistant genes | |
AU1372897A (en) | 2-amino-heterocycles and therapeutic uses therefor | |
AU3737297A (en) | Bacteriophage-mediated gene therapy | |
AU1616499A (en) | Chemokine variants and methods of use | |
AU9334998A (en) | Processing and use of carbide lime | |
AU2749395A (en) | Medical use of bromelain | |
AU7290898A (en) | Preparation of fagopyritols and uses therefor | |
AU6282896A (en) | Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins | |
HK1063004A1 (en) | Oxalatoplatin and 5-fluorouracil for combination therapy of cancer | |
AU694270B2 (en) | Biologically active silicon compounds and their therapeutic and cosmetic applications | |
AU2510799A (en) | Novel sequence variants of the human beta2-adrenergic receptor gene and use thereof | |
AU9001898A (en) | Beta-fructofuranosidase and gene thereof | |
AU2438695A (en) | Therapeutic phenoxyalkylpyridazines and intermediates therefor | |
AU3793297A (en) | Stabilization and oral delivery of calcitonin | |
AU5221998A (en) | Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors | |
AU8168898A (en) | Interferon stimulating protein and uses thereof | |
AU7529796A (en) | S-nitroso-hemoglobin and therapeutic uses thereof | |
AU6582698A (en) | Therapeutic uses of grip and grip-related molecules | |
AU6957198A (en) | Cytokine and cisplatin-based gene therapy of carcinomas |